A Dose Escalation Study to Evaluate the Effect of Inhaled Nitrite on Cardiopulmonary Hemodynamics in Subjects With Pulmonary Hypertension
Phase of Trial: Phase II
Latest Information Update: 05 Oct 2017
At a glance
- Drugs Sodium nitrite (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- 29 Sep 2017 Planned End Date changed from 1 May 2017 to 1 Dec 2017.
- 29 Sep 2017 Planned primary completion date changed from 1 May 2017 to 1 Dec 2017.
- 11 Jul 2017 According to a Savara Pharmaceuticals media release, results from this trial were presented at the 4th Annual Drug Discovery and Development Symposium for Pulmonary Hypertension.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History